Juliana F. Silva
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Morphology-Guided Screening of PLA/Cellulose Biocomposites for Melt-Spun Monofilaments: Micronized Eucalyptus Kraft Pulp Versus Microcrystalline Cellulose.
Journal: Polymers
Published: June 15, 2026
Outcomes of invasive fungal infections in 358 children undergoing allogeneic haematopoietic stem cell transplantation: A prospective UK study.
Journal: British journal of haematology
Published: January 15, 2026
Treosulfan-fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan study.
Journal: British journal of haematology
Published: October 27, 2025
The impact of pre-transplant extramedullary disease on the outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in children- on behalf of PDWP/EBMT.
Journal: Bone marrow transplantation
Published: July 29, 2025
Evaluating the relevance of the 2024 BSR systemic sclerosis guideline for juvenile systemic sclerosis.
Journal: Rheumatology (Oxford, England)
Published: May 11, 2025
Guidance for stem cell therapy for juvenile systemic sclerosis patients.
Journal: Expert review of clinical immunology
Published: March 08, 2025
Defining a CMV viral load threshold for pre-emptive therapy in paediatric haematopoietic stem cell transplant recipients.
Journal: British journal of haematology
Published: February 07, 2025
Safety and Diagnostic Utility of Brain Biopsy and Metagenomics in Decision-Making for Patients with Inborn Errors of Immunity (IEI) and Unexplained Neurological Manifestations.
Journal: Journal of clinical immunology
Published: June 24, 2024
Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe.
Journal: Pediatric rheumatology online journal
Published: January 05, 2024
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.
Journal: Blood cancer journal
Published: December 01, 2023
Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts.
Journal: Transplantation and cellular therapy
Published: September 09, 2023
Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy.
Journal: Blood advances
Published: July 10, 2023
Last Updated: 09/26/2026